Multi-target siRNA: Therapeutic Strategy for Hepatocellular Carcinoma

Multiple targets RNAi strategy is a preferred way to treat multigenic diseases, especially cancers. In the study, multi-target siRNAs were designed to inhibit NET-1, EMS1 and VEGF genes in hepatocellular carcinoma (HCC) cells. And multi-target siRNAs showed better silencing effects on NET-1, EMS1 an...

詳細記述

保存先:
書誌詳細
出版年:J Cancer
主要な著者: Li, Tiejun, Xue, Yuwen, Wang, Guilan, Gu, Tingting, Li, Yunlong, Zhu, York Yuanyuan, Chen, Li
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2016
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4934040/
https://ncbi.nlm.nih.gov/pubmed/27390607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.15157
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料